Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

payer survey

ccura logo

Cuttsy+Cuttsy launches ccura: AI powered, always human

Cuttsy+Cuttsy introduces ccura, an AI-powered healthcare communications platform that blends technology with human expertise to enhance collaboration, streamline workflows, and deliver patient-focused, high-quality solutions with security and compliance at its...

Cuttsy + Cuttsy

- PMLiVE

Your essential guide to the World EPA Congress 2025: Top sessions and pre-reading

The World EPA organisers have curated an exceptional programme featuring thought-provoking presentations and dynamic panel sessions led by industry leaders driving market access strategy and practice. Following the opening keynote...

Petauri Evidence

- PMLiVE

How can a digital PR strategy elevate your company’s profile? A spotlight on mental health

In the ever-evolving healthcare media landscape, Digital PR bridges the traditional benefits of reach, share of voice, and sentiment with the power of Search Engine Optimization (SEO)—delivering both meaningful connections...

EatMoreFruit

EU flag

EC approves Galderma’s Nemluvio to treat atopic dermatitis and prurigo nodularis

Nemluvio is now the first approved monoclonal antibody that specifically targets interleukin-31 receptor alpha

- PMLiVE

Bristol Myers Squibb shares five-year results for Sotyktu in plaque psoriasis

Plaque psoriasis affects up to 90% of patients with the immune-mediated disease

- PMLiVE

FDA approves Bavarian Nordic’s chikungunya vaccine for individuals aged from 12 years

The mosquito-borne viral disease has been reported across many popular travel destinations

- PMLiVE

GSK’s five-in-one meningococcal vaccine Penmenvy granted FDA approval

It is hoped that the combination vaccine will simplify delivery and lead to higher uptake

- PMLiVE

Pfizer/Astellas share positive phase 3 results for Padcev in bladder cancer

Approximately 614,000 people are diagnosed with bladder cancer globally every year

- PMLiVE

Sobi receives MHRA approval for Altuvoct in severe or moderate haemophilia A

The factor VIII replacement therapy has been authorised to treat and prevent bleeding in children and adults

- PMLiVE

AbbVie and Xilio announce immunotherapy partnership worth over $2.1bn

The companies will aim to develop tumour-activated immunotherapies, including masked T-cell engagers

- PMLiVE

Roche’s Evrysdi tablet formulation granted FDA approval for spinal muscular atrophy

The progressive neuromuscular disease affects approximately one in every 10,000 babies globally

EU flag

EC approves CSL’s Andembry to prevent hereditary angioedema attacks

Approximately one in every 50,000 people worldwide are affected by the rare genetic disorder

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links